(1) The Department of Human Services shall ensure that the Arkansas Medicaid Program covers medications approved by the United States Food and Drug Administration for tobacco cessation, including without limitation: Nicotine replacement therapy patches;
(2) Nicotine replacement therapy gum;
(3) Nicotine replacement therapy lozenges;
(4) Nicotine replacement therapy nasal spray;
(5) Nicotine replacement therapy inhalers;
(6) Bupropion; and
(7) Varenicline.
(8) Prior authorization shall not be required for coverage of medications described in subsection (a) of this section.